ArticleJournal of hepatocellular carcinoma2026
Baseline Sleep Quality and Objective Response in HCC Patients Treated with TACE Combined with Lenvatinib and PD-1 Inhibitors: A Secondary Analysis of a Prospectively Registered Observational Cohort.
Pengfei Tian et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.